Found: 16
Select item for more details and to access through your institution.
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 187, n. 2, p. 467, doi. 10.1007/s10549-021-06145-3
- By:
- Publication type:
- Article
A Comparative Analysis on the Efficacy and Safety of Intaxel® and Taxol® in Advanced Metastatic Breast Cancer.
- Published in:
- Journal of Clinical & Diagnostic Research, 2013, v. 7, n. 6, p. 1120, doi. 10.7860/JCDR/2013/4742.3027
- By:
- Publication type:
- Article
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study
- Published in:
- Thyroid, 2024, v. 34, n. 3, p. 347, doi. 10.1089/thy.2023.0463
- By:
- Publication type:
- Article
Colorectalis májmetastasisok komplex kezelése. Konszenzuskonferencia, Budapest, 2019. április 5.
- Published in:
- Hungarian Medical Journal / Orvosi Hetilap, 2019, v. 160, p. 2, doi. 10.1556/650.2019.31580
- By:
- Publication type:
- Article
Corrigendum: High Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer.
- Published in:
- Pathology & Oncology Research, 2022, v. 28, p. 1, doi. 10.3389/pore.2022.1610658
- By:
- Publication type:
- Article
Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal Cancer.
- Published in:
- Pathology & Oncology Research, 2020, v. 26, n. 4, p. 2683, doi. 10.1007/s12253-020-00865-5
- By:
- Publication type:
- Article
Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer.
- Published in:
- Pathology & Oncology Research, 2018, v. 24, n. 2, p. 237, doi. 10.1007/s12253-017-0238-y
- By:
- Publication type:
- Article
Capecitabine in Combination with Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: an Observational Study.
- Published in:
- Pathology & Oncology Research, 2017, v. 23, n. 3, p. 505, doi. 10.1007/s12253-016-0129-7
- By:
- Publication type:
- Article
Inflammatory Breast Cancer-Comparing the Effectivity of Preoperative Docetaxel-Epirubicine Protocol to Conventional Antracycline-Containing Chemotherapy to Achieve Clinical Benefit and Complete Pathological Response.
- Published in:
- Pathology & Oncology Research, 2011, v. 17, n. 3, p. 541, doi. 10.1007/s12253-010-9344-9
- By:
- Publication type:
- Article
Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients.
- Published in:
- International Journal of Cancer, 2004, v. 108, n. 6, p. 852, doi. 10.1002/ijc.11641
- By:
- Publication type:
- Article
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 3, p. 558, doi. 10.1007/s10120-024-01466-w
- By:
- Publication type:
- Article
Cabozantinib for previously treated radioiodine‐refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC‐311 trial.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4203, doi. 10.1002/cncr.34493
- By:
- Publication type:
- Article
Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.
- Published in:
- 2019
- By:
- Publication type:
- journal article
SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.
- Published in:
- BMC Cancer, 2010, v. 10, p. 525, doi. 10.1186/1471-2407-10-525
- By:
- Publication type:
- Article
Common NOD2/CARD 15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients.
- Published in:
- BMC Cancer, 2007, v. 7, p. 54, doi. 10.1186/1471-2407-7-54
- By:
- Publication type:
- Article